The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study
Introduction The literature lacks formally validated and reliable tools for the diagnosis of breakthrough cancer pain (BTcP). The Italian Questionnaire for BTcP diagnosis (IQ-BTP) is an 11-item questionnaire aimed at detecting potential-BTP and classifying it into three likelihood classes: high, int...
Gespeichert in:
Veröffentlicht in: | Pain and Therapy 2021-12, Vol.10 (2), p.1171-1188 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1188 |
---|---|
container_issue | 2 |
container_start_page | 1171 |
container_title | Pain and Therapy |
container_volume | 10 |
creator | Samolsky Dekel, Boaz Gedaliahu Gori, Alberto Gunnellini, Marco Gioia, Angela Di Marco, Mariacristina Casale, Giuseppe Bevilacqua, Marzio Bersani, Pietro Melotti, Rita Maria |
description | Introduction
The literature lacks formally validated and reliable tools for the diagnosis of breakthrough cancer pain (BTcP). The Italian Questionnaire for BTcP diagnosis (IQ-BTP) is an 11-item questionnaire aimed at detecting potential-BTP and classifying it into three likelihood classes: high, intermediate, and low.
Methods
A multicenter, prospective, and observational study was designed to validate the IQ-BTP. In three consecutive visits with each cancer patient, the demographic and clinical details of the patient, the Brief Pain Inventory (BPI) scores, IQ-BTP outcomes, and clinicians' autonomous BTcP diagnosis (gold standard) and the agreement of this diagnosis with IQ-BTP outcomes were recorded. The assessed domains for IQ-BTP validation were: Validity, including content and face validity, construct validity (hypothesis testing, and cross‐cultural validity\measurement invariance), and criterion validity; Reliability (internal consistency, reliability, and measurement error); Interpretability, and Responsiveness.
Results
Seven palliative and pain management facilities in Italy recruited 280 patients, yielding 753 evaluations. Using the IQ-BTP, the rate of potential-BTcP was 27.2%, of which its likely presence was high in 52.7% of patients, intermediate in 38.5, and low in 8.8%. The BPI item scores differed significantly between the two IQ-BTP classes (no-BTcP and potential-BTcP classes). The correlation of the latter class with BPI items was significant but low. The IQ-BTcP showed two principal components, accounting for 66.6% of the variance. Cronbach’s
α
was 0.71. The agreement rate between the gold standard and IQ-BTP outcomes was 82%. Cohen's
κ
was 0.535. The IQ-BTP showed sensitivity and specificity of 69 and 86%, respectively.
Conclusions
The IQ-BTP extensive formal validation showed satisfactory psychometric and validity properties. Its content, face, construct, and criterion validities and its reliability, interpretability, and responsiveness were shown. Its use enabled potential-BTcP to be identified and differentiated into three likelihood classes with direct therapeutic and epidemiological implications. The latter may be confirmed in future studies. |
doi_str_mv | 10.1007/s40122-021-00274-9 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A682168763</galeid><sourcerecordid>A682168763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-deff5273e99532067151773ed66d75f3e78c81f0f7f2a8a3a67871fefab1df013</originalsourceid><addsrcrecordid>eNp9kUtv1TAQhS0EolXpH2CBvGRBih9x7GyQyuVVqQgQBbEz02Sc65Jrt3aC1H-PQy4VbJAXfsw5n8ZzCHnM2QlnTD_PNeNCVEzwijGh66q9Rw4Fb2XVKP7t_v5shNQH5DjnK8aK3qi2Vg_JgaxZyw3Xh-T7xRbp2QSjh0A_zZgnH0MAn5C6mOgGQoeJvkwIP6ZtivOwpR_BB_rKwxBi9vkZBfp-HiffYZiK9GtB9bBQ6Odp7m8fkQcOxozH-_2IfHnz-mLzrjr_8PZsc3pedYrLqerROSW0xLZVUrBGc8V1ufZN02vlJGrTGe6Y006AAQmNNpo7dHDJe8e4PCIvVu71fLnDfukmwWivk99BurURvP23EvzWDvGnNco0UiyAp3tAijfLIOzO5w7HEQLGOVuhpGG1VlIV6ckqHWBE64OLhdiV1ePOdzGg8-X9tDGCN0Y3shjEauhSzDmhu-uLM7vEadc4bYnT_o7TtsX05O8f3Vn-hFcEchXkUgoDJnsV5xTKlP-H_QU4DawA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2538047535</pqid></control><display><type>article</type><title>The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Samolsky Dekel, Boaz Gedaliahu ; Gori, Alberto ; Gunnellini, Marco ; Gioia, Angela ; Di Marco, Mariacristina ; Casale, Giuseppe ; Bevilacqua, Marzio ; Bersani, Pietro ; Melotti, Rita Maria</creator><creatorcontrib>Samolsky Dekel, Boaz Gedaliahu ; Gori, Alberto ; Gunnellini, Marco ; Gioia, Angela ; Di Marco, Mariacristina ; Casale, Giuseppe ; Bevilacqua, Marzio ; Bersani, Pietro ; Melotti, Rita Maria</creatorcontrib><description>Introduction
The literature lacks formally validated and reliable tools for the diagnosis of breakthrough cancer pain (BTcP). The Italian Questionnaire for BTcP diagnosis (IQ-BTP) is an 11-item questionnaire aimed at detecting potential-BTP and classifying it into three likelihood classes: high, intermediate, and low.
Methods
A multicenter, prospective, and observational study was designed to validate the IQ-BTP. In three consecutive visits with each cancer patient, the demographic and clinical details of the patient, the Brief Pain Inventory (BPI) scores, IQ-BTP outcomes, and clinicians' autonomous BTcP diagnosis (gold standard) and the agreement of this diagnosis with IQ-BTP outcomes were recorded. The assessed domains for IQ-BTP validation were: Validity, including content and face validity, construct validity (hypothesis testing, and cross‐cultural validity\measurement invariance), and criterion validity; Reliability (internal consistency, reliability, and measurement error); Interpretability, and Responsiveness.
Results
Seven palliative and pain management facilities in Italy recruited 280 patients, yielding 753 evaluations. Using the IQ-BTP, the rate of potential-BTcP was 27.2%, of which its likely presence was high in 52.7% of patients, intermediate in 38.5, and low in 8.8%. The BPI item scores differed significantly between the two IQ-BTP classes (no-BTcP and potential-BTcP classes). The correlation of the latter class with BPI items was significant but low. The IQ-BTcP showed two principal components, accounting for 66.6% of the variance. Cronbach’s
α
was 0.71. The agreement rate between the gold standard and IQ-BTP outcomes was 82%. Cohen's
κ
was 0.535. The IQ-BTP showed sensitivity and specificity of 69 and 86%, respectively.
Conclusions
The IQ-BTP extensive formal validation showed satisfactory psychometric and validity properties. Its content, face, construct, and criterion validities and its reliability, interpretability, and responsiveness were shown. Its use enabled potential-BTcP to be identified and differentiated into three likelihood classes with direct therapeutic and epidemiological implications. The latter may be confirmed in future studies.</description><identifier>ISSN: 2193-8237</identifier><identifier>EISSN: 2193-651X</identifier><identifier>DOI: 10.1007/s40122-021-00274-9</identifier><identifier>PMID: 34091817</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cancer pain ; Cancer patients ; Diagnosis ; Evaluation ; Health surveys ; Internal Medicine ; Medicine ; Medicine & Public Health ; Original Research ; Pain Medicine ; Surveys</subject><ispartof>Pain and Therapy, 2021-12, Vol.10 (2), p.1171-1188</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2021 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-deff5273e99532067151773ed66d75f3e78c81f0f7f2a8a3a67871fefab1df013</citedby><cites>FETCH-LOGICAL-c513t-deff5273e99532067151773ed66d75f3e78c81f0f7f2a8a3a67871fefab1df013</cites><orcidid>0000-0002-6458-3562 ; 0000-0002-5583-4892 ; 0000-0002-8392-385X ; 0000-0002-3470-9494 ; 0000-0002-9954-4117 ; 0000-0001-5932-9212 ; 0000-0001-6461-1466 ; 0000-0001-6258-6607 ; 0000-0002-9154-5860</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586321/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586321/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34091817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samolsky Dekel, Boaz Gedaliahu</creatorcontrib><creatorcontrib>Gori, Alberto</creatorcontrib><creatorcontrib>Gunnellini, Marco</creatorcontrib><creatorcontrib>Gioia, Angela</creatorcontrib><creatorcontrib>Di Marco, Mariacristina</creatorcontrib><creatorcontrib>Casale, Giuseppe</creatorcontrib><creatorcontrib>Bevilacqua, Marzio</creatorcontrib><creatorcontrib>Bersani, Pietro</creatorcontrib><creatorcontrib>Melotti, Rita Maria</creatorcontrib><title>The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study</title><title>Pain and Therapy</title><addtitle>Pain Ther</addtitle><addtitle>Pain Ther</addtitle><description>Introduction
The literature lacks formally validated and reliable tools for the diagnosis of breakthrough cancer pain (BTcP). The Italian Questionnaire for BTcP diagnosis (IQ-BTP) is an 11-item questionnaire aimed at detecting potential-BTP and classifying it into three likelihood classes: high, intermediate, and low.
Methods
A multicenter, prospective, and observational study was designed to validate the IQ-BTP. In three consecutive visits with each cancer patient, the demographic and clinical details of the patient, the Brief Pain Inventory (BPI) scores, IQ-BTP outcomes, and clinicians' autonomous BTcP diagnosis (gold standard) and the agreement of this diagnosis with IQ-BTP outcomes were recorded. The assessed domains for IQ-BTP validation were: Validity, including content and face validity, construct validity (hypothesis testing, and cross‐cultural validity\measurement invariance), and criterion validity; Reliability (internal consistency, reliability, and measurement error); Interpretability, and Responsiveness.
Results
Seven palliative and pain management facilities in Italy recruited 280 patients, yielding 753 evaluations. Using the IQ-BTP, the rate of potential-BTcP was 27.2%, of which its likely presence was high in 52.7% of patients, intermediate in 38.5, and low in 8.8%. The BPI item scores differed significantly between the two IQ-BTP classes (no-BTcP and potential-BTcP classes). The correlation of the latter class with BPI items was significant but low. The IQ-BTcP showed two principal components, accounting for 66.6% of the variance. Cronbach’s
α
was 0.71. The agreement rate between the gold standard and IQ-BTP outcomes was 82%. Cohen's
κ
was 0.535. The IQ-BTP showed sensitivity and specificity of 69 and 86%, respectively.
Conclusions
The IQ-BTP extensive formal validation showed satisfactory psychometric and validity properties. Its content, face, construct, and criterion validities and its reliability, interpretability, and responsiveness were shown. Its use enabled potential-BTcP to be identified and differentiated into three likelihood classes with direct therapeutic and epidemiological implications. The latter may be confirmed in future studies.</description><subject>Cancer pain</subject><subject>Cancer patients</subject><subject>Diagnosis</subject><subject>Evaluation</subject><subject>Health surveys</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Research</subject><subject>Pain Medicine</subject><subject>Surveys</subject><issn>2193-8237</issn><issn>2193-651X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kUtv1TAQhS0EolXpH2CBvGRBih9x7GyQyuVVqQgQBbEz02Sc65Jrt3aC1H-PQy4VbJAXfsw5n8ZzCHnM2QlnTD_PNeNCVEzwijGh66q9Rw4Fb2XVKP7t_v5shNQH5DjnK8aK3qi2Vg_JgaxZyw3Xh-T7xRbp2QSjh0A_zZgnH0MAn5C6mOgGQoeJvkwIP6ZtivOwpR_BB_rKwxBi9vkZBfp-HiffYZiK9GtB9bBQ6Odp7m8fkQcOxozH-_2IfHnz-mLzrjr_8PZsc3pedYrLqerROSW0xLZVUrBGc8V1ufZN02vlJGrTGe6Y006AAQmNNpo7dHDJe8e4PCIvVu71fLnDfukmwWivk99BurURvP23EvzWDvGnNco0UiyAp3tAijfLIOzO5w7HEQLGOVuhpGG1VlIV6ckqHWBE64OLhdiV1ePOdzGg8-X9tDGCN0Y3shjEauhSzDmhu-uLM7vEadc4bYnT_o7TtsX05O8f3Vn-hFcEchXkUgoDJnsV5xTKlP-H_QU4DawA</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Samolsky Dekel, Boaz Gedaliahu</creator><creator>Gori, Alberto</creator><creator>Gunnellini, Marco</creator><creator>Gioia, Angela</creator><creator>Di Marco, Mariacristina</creator><creator>Casale, Giuseppe</creator><creator>Bevilacqua, Marzio</creator><creator>Bersani, Pietro</creator><creator>Melotti, Rita Maria</creator><general>Springer Healthcare</general><general>Springer</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6458-3562</orcidid><orcidid>https://orcid.org/0000-0002-5583-4892</orcidid><orcidid>https://orcid.org/0000-0002-8392-385X</orcidid><orcidid>https://orcid.org/0000-0002-3470-9494</orcidid><orcidid>https://orcid.org/0000-0002-9954-4117</orcidid><orcidid>https://orcid.org/0000-0001-5932-9212</orcidid><orcidid>https://orcid.org/0000-0001-6461-1466</orcidid><orcidid>https://orcid.org/0000-0001-6258-6607</orcidid><orcidid>https://orcid.org/0000-0002-9154-5860</orcidid></search><sort><creationdate>20211201</creationdate><title>The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study</title><author>Samolsky Dekel, Boaz Gedaliahu ; Gori, Alberto ; Gunnellini, Marco ; Gioia, Angela ; Di Marco, Mariacristina ; Casale, Giuseppe ; Bevilacqua, Marzio ; Bersani, Pietro ; Melotti, Rita Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-deff5273e99532067151773ed66d75f3e78c81f0f7f2a8a3a67871fefab1df013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer pain</topic><topic>Cancer patients</topic><topic>Diagnosis</topic><topic>Evaluation</topic><topic>Health surveys</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Research</topic><topic>Pain Medicine</topic><topic>Surveys</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samolsky Dekel, Boaz Gedaliahu</creatorcontrib><creatorcontrib>Gori, Alberto</creatorcontrib><creatorcontrib>Gunnellini, Marco</creatorcontrib><creatorcontrib>Gioia, Angela</creatorcontrib><creatorcontrib>Di Marco, Mariacristina</creatorcontrib><creatorcontrib>Casale, Giuseppe</creatorcontrib><creatorcontrib>Bevilacqua, Marzio</creatorcontrib><creatorcontrib>Bersani, Pietro</creatorcontrib><creatorcontrib>Melotti, Rita Maria</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pain and Therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samolsky Dekel, Boaz Gedaliahu</au><au>Gori, Alberto</au><au>Gunnellini, Marco</au><au>Gioia, Angela</au><au>Di Marco, Mariacristina</au><au>Casale, Giuseppe</au><au>Bevilacqua, Marzio</au><au>Bersani, Pietro</au><au>Melotti, Rita Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study</atitle><jtitle>Pain and Therapy</jtitle><stitle>Pain Ther</stitle><addtitle>Pain Ther</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>10</volume><issue>2</issue><spage>1171</spage><epage>1188</epage><pages>1171-1188</pages><issn>2193-8237</issn><eissn>2193-651X</eissn><abstract>Introduction
The literature lacks formally validated and reliable tools for the diagnosis of breakthrough cancer pain (BTcP). The Italian Questionnaire for BTcP diagnosis (IQ-BTP) is an 11-item questionnaire aimed at detecting potential-BTP and classifying it into three likelihood classes: high, intermediate, and low.
Methods
A multicenter, prospective, and observational study was designed to validate the IQ-BTP. In three consecutive visits with each cancer patient, the demographic and clinical details of the patient, the Brief Pain Inventory (BPI) scores, IQ-BTP outcomes, and clinicians' autonomous BTcP diagnosis (gold standard) and the agreement of this diagnosis with IQ-BTP outcomes were recorded. The assessed domains for IQ-BTP validation were: Validity, including content and face validity, construct validity (hypothesis testing, and cross‐cultural validity\measurement invariance), and criterion validity; Reliability (internal consistency, reliability, and measurement error); Interpretability, and Responsiveness.
Results
Seven palliative and pain management facilities in Italy recruited 280 patients, yielding 753 evaluations. Using the IQ-BTP, the rate of potential-BTcP was 27.2%, of which its likely presence was high in 52.7% of patients, intermediate in 38.5, and low in 8.8%. The BPI item scores differed significantly between the two IQ-BTP classes (no-BTcP and potential-BTcP classes). The correlation of the latter class with BPI items was significant but low. The IQ-BTcP showed two principal components, accounting for 66.6% of the variance. Cronbach’s
α
was 0.71. The agreement rate between the gold standard and IQ-BTP outcomes was 82%. Cohen's
κ
was 0.535. The IQ-BTP showed sensitivity and specificity of 69 and 86%, respectively.
Conclusions
The IQ-BTP extensive formal validation showed satisfactory psychometric and validity properties. Its content, face, construct, and criterion validities and its reliability, interpretability, and responsiveness were shown. Its use enabled potential-BTcP to be identified and differentiated into three likelihood classes with direct therapeutic and epidemiological implications. The latter may be confirmed in future studies.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>34091817</pmid><doi>10.1007/s40122-021-00274-9</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-6458-3562</orcidid><orcidid>https://orcid.org/0000-0002-5583-4892</orcidid><orcidid>https://orcid.org/0000-0002-8392-385X</orcidid><orcidid>https://orcid.org/0000-0002-3470-9494</orcidid><orcidid>https://orcid.org/0000-0002-9954-4117</orcidid><orcidid>https://orcid.org/0000-0001-5932-9212</orcidid><orcidid>https://orcid.org/0000-0001-6461-1466</orcidid><orcidid>https://orcid.org/0000-0001-6258-6607</orcidid><orcidid>https://orcid.org/0000-0002-9154-5860</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2193-8237 |
ispartof | Pain and Therapy, 2021-12, Vol.10 (2), p.1171-1188 |
issn | 2193-8237 2193-651X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8586321 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA Free Journals |
subjects | Cancer pain Cancer patients Diagnosis Evaluation Health surveys Internal Medicine Medicine Medicine & Public Health Original Research Pain Medicine Surveys |
title | The Italian Questionnaire for Cancer Breakthrough Pain Diagnosis, a Multicenter Validation Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A42%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Italian%20Questionnaire%20for%20Cancer%20Breakthrough%20Pain%20Diagnosis,%20a%20Multicenter%20Validation%20Study&rft.jtitle=Pain%20and%20Therapy&rft.au=Samolsky%20Dekel,%20Boaz%20Gedaliahu&rft.date=2021-12-01&rft.volume=10&rft.issue=2&rft.spage=1171&rft.epage=1188&rft.pages=1171-1188&rft.issn=2193-8237&rft.eissn=2193-651X&rft_id=info:doi/10.1007/s40122-021-00274-9&rft_dat=%3Cgale_pubme%3EA682168763%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2538047535&rft_id=info:pmid/34091817&rft_galeid=A682168763&rfr_iscdi=true |